Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Fierce Pharma
Tue, 01/26/16 - 09:01 pm
Amgen
biosimilars
Humira
FDA
AbbVie
FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501
Yahoo
Mon, 01/25/16 - 10:22 pm
FDA
Amgen
biosimilars
biologics
ABP 501
Humira
Amgen Loses Enbrel to Biogen in Europe; Can It Cope?
Bidness, ETC
Tue, 01/19/16 - 10:39 am
Amgen
Biogen
Europe
Enbrel
Samsung Bioepis
biosimilars
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Tue, 01/12/16 - 02:37 pm
Big Pharma
biosimilars
Roche
AbbVie
MabThera
Herceptin
Avastin
Humira
Janssen
Remicade
Baxalta, Coherus say Enbrel biosimilar succeeds in study
Yahoo/Reuters
Mon, 01/11/16 - 08:36 am
Baxalta
Coherus Biosciences
biosimilars
Enbrel
rheumatoid arthritis
CHS-0214
Mylan, Momenta Team Up To Develop Biosimilar Drugs
Investors.com
Sat, 01/9/16 - 10:32 am
Mylan Labs
Momenta
biosimilars
R&D
2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
TheStreet.com
Thu, 01/7/16 - 01:02 pm
biotech
Celgene
biosimilars
Isis Pharmaceuticals
CAR-T
Bluebird Bio
Puma Biotechnology
MannKind
The biosimilars are coming. But how long will it be till they can make their mark?
Fierce Pharma
Sat, 12/26/15 - 08:49 pm
biosimilars
Sanofi
Amgen
Eli Lilly
Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar
BioPharma Dive
Thu, 12/17/15 - 02:00 pm
diabetes
Eli Lilly
Lantus
Basaglar
insulin
FDA
biosimilars
Sanofi
The Ever-Expanding Biosimilar Labeling Debate – Institutional Investors Offer their Opinion and Request FDA to Hold a Hearing
FDA Law Blog
Fri, 12/11/15 - 09:40 am
FDA
biosimilars
Amgen stalls Apotex's Neulasta biosim launch with court victory
Fierce Pharma
Thu, 12/10/15 - 06:44 pm
Amgen
Apotex
Neulasta
biosimilars
Amgen's First Biosimilar Marketing Authorization Application Submitted To European Medicines Agency For ABP 501
Yahoo
Fri, 12/4/15 - 01:40 pm
Amgen
biosimilars
Europe
Humira
ABP 501
Why AbbVie was not Impacted by Amgen Humira Biosimilar Submission
Bidness, ETC
Mon, 11/30/15 - 09:27 am
AbbVie
Humira
Amgen
biosimilars
ABP 501
Amgen applies to FDA for competitor drug to AbbVie's Humira
Marketwatch
Wed, 11/25/15 - 06:43 pm
Amgen
FDA
AbbVie
Humira
biosimilars
psoriasis
Biogen and Samsung's Enbrel biosimilar wins EMA nod for EU approval
Fierce Pharma
Fri, 11/20/15 - 06:21 pm
Biogen
Samsung
Enbrel
biosimilars
Europe
Pfizer
Amgen
anti-TNF
Novartis biosimilar takes aim at Amgen drug Neulasta
Yahoo/Reuters
Wed, 11/18/15 - 09:30 am
Novartis
Amgen
biosimilars
Neulasta
Sandoz
Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Fierce Biotech
Wed, 11/11/15 - 10:04 am
Amgen
Humira
biosimilars
rheumatoid arthritis
AbbVie Calms Humira Biosimilar Fears
WSJ Online
Mon, 11/2/15 - 08:08 am
AbbVie
Humira
biosimilars
FTC raises anticompetitive concerns about FDA naming proposal for biosimilars
Pharmalot
Thu, 10/29/15 - 06:16 pm
FTC
FDA
biosimilars
drug names
Amgen's Innovation Counters Biosimilar Pressure
Morningstar
Mon, 10/19/15 - 10:03 am
Amgen
innovation
biosimilars
Epogen
Aranesp
Neupogen
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »